Chirovsky D - Search Results

1

5-year real-world outcomes with first-line pembrolizumab plus chemotherapy in advanced/metastatic NSCLC.

Liu SV, Babel RA, Kao YH, Chirovsky D, Namakydoust A, Velcheti V. Liu SV, et al. Among authors: chirovsky d. Immunotherapy. 2025 Oct;17(14):1005-1013. doi: 10.1080/1750743X.2025.2569856. Epub 2025 Oct 17. Immunotherapy. 2025. PMID: 41104445

2

Lenvatinib Plus Pembrolizumab, Pemetrexed, and a Platinum as First-Line Therapy for Metastatic Nonsquamous NSCLC: Phase 3 LEAP-006 Study.

Herbst RS, Cho BC, Zhou C, Burotto M, Dols MC, Sendur MAN, Moiseyenko V, Casarini I, Nishio M, Hui R, Pons-Tostivint E, Dudnik J, Ahmed S, Okpara CE, Dutcus C, Yin L, Luo Y, Chirovsky D, Bhagwati N, Abreu DR. Herbst RS, et al. Among authors: chirovsky d. J Thorac Oncol. 2025 Sep;20(9):1302-1314. doi: 10.1016/j.jtho.2025.05.016. Epub 2025 May 24. J Thorac Oncol. 2025. PMID: 40419140 Free article. Clinical Trial.

3

Long-term real-world outcomes of first-line immunotherapy in non-small cell lung cancer - a population-based cohort study in Sweden.

Wagenius G, Vikström A, Berglund A, Salomonsson S, Bencina G, Hu X, Chirovsky D, Brunnström H. Wagenius G, et al. Among authors: chirovsky d. Acta Oncol. 2025 Mar 17;64:415-422. doi: 10.2340/1651-226X.2025.42746. Acta Oncol. 2025. PMID: 40094477 Free PMC article.

4

Expression of PD-L1, PD-L2, and inflammatory gene expression profile in locally advanced head and neck squamous cell carcinoma.

Hong MH, Park S, Vo T, Cho J, Jung HA, Lee SH, Kim SH, Zhou H, Chirovsky D, Koh YW, Yoon SO, Webber AL, Gumuscu B, Cho BC, Ahn MJ. Hong MH, et al. Among authors: chirovsky d. ESMO Open. 2024 Nov;9(11):103961. doi: 10.1016/j.esmoop.2024.103961. Epub 2024 Oct 25. ESMO Open. 2024. PMID: 39461260 Free PMC article.

5

Phase III KEYNOTE-789 Study of Pemetrexed and Platinum With or Without Pembrolizumab for Tyrosine Kinase Inhibitor‒Resistant, EGFR-Mutant, Metastatic Nonsquamous Non-Small Cell Lung Cancer.

Yang JC, Lee DH, Lee JS, Fan Y, de Marinis F, Iwama E, Inoue T, Rodríguez-Cid J, Zhang L, Yang CT, de la Mora Jimenez E, Zhou J, Pérol M, Lee KH, Vicente D, Ichihara E, Riely GJ, Luo Y, Chirovsky D, Pietanza MC, Bhagwati N, Lu S. Yang JC, et al. Among authors: chirovsky d. J Clin Oncol. 2024 Dec;42(34):4029-4039. doi: 10.1200/JCO.23.02747. Epub 2024 Aug 22. J Clin Oncol. 2024. PMID: 39173098 Free PMC article. Clinical Trial.

6

A retrospective analysis of treatment patterns, overall survival, and real-world disease-free survival in early-stage non-small cell lung cancer following complete resection.

Hu X, Chirovsky D, Walker MS, Wang Y, Kaushiva A, Tepsick J, Samkari A. Hu X, et al. Among authors: chirovsky d. BMC Pulm Med. 2024 Jul 10;24(1):332. doi: 10.1186/s12890-024-03138-y. BMC Pulm Med. 2024. PMID: 38987763 Free PMC article.

7

5-Year Real-World Outcomes With Frontline Pembrolizumab Monotherapy in PD-L1 Expression ≥ 50% Advanced NSCLC.

Velcheti V, Rai P, Kao YH, Chirovsky D, Nunes AT, Liu SV. Velcheti V, et al. Among authors: chirovsky d. Clin Lung Cancer. 2024 Sep;25(6):502-508.e3. doi: 10.1016/j.cllc.2024.05.002. Epub 2024 May 16. Clin Lung Cancer. 2024. PMID: 38880664 Free article.

8

Real-world outcomes on platinum-containing chemotherapy for EGFR-mutated advanced nonsquamous NSCLC with prior exposure to EGFR tyrosine kinase inhibitors.

Halmos B, Rai P, Min J, Hu X, Chirovsky D, Shamoun M, Zhao B. Halmos B, et al. Among authors: chirovsky d. Front Oncol. 2024 Apr 18;14:1285280. doi: 10.3389/fonc.2024.1285280. eCollection 2024. Front Oncol. 2024. PMID: 38699642 Free PMC article.

9

First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy.

Wagenius G, Vikström A, Berglund A, Salomonsson S, Bencina G, Hu X, Chirovsky D, Brunnström H. Wagenius G, et al. Among authors: chirovsky d. Acta Oncol. 2024 Apr 21;63:198-205. doi: 10.2340/1651-226X.2024.20309. Acta Oncol. 2024. PMID: 38643377 Free PMC article.

10

Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer.

Donington J, Hu X, Zhang S, Song Y, Arunachalam A, Chirovsky D, Gao C, Lerner A, Jiang A, Signorovitch J, Samkari A. Donington J, et al. Among authors: chirovsky d. Clin Lung Cancer. 2024 Jul;25(5):440-448. doi: 10.1016/j.cllc.2024.03.006. Epub 2024 Mar 22. Clin Lung Cancer. 2024. PMID: 38627155

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters